Browsing by Subject "Special populations"

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    Measles: Contemporary considerations for the emergency physician
    (Wiley, 2023-09-09) Blutinger, Erik; Schmitz, Gillian; Kang, Christopher; Comp, Geoffrey; Wagner, Emily; Finnell, John T.; Cozzi, Nicolas; Haddock, Alison; Emergency Medicine, School of Medicine
    Measles, or rubeola, is a highly contagious acute febrile viral illness. Despite the availability of an effective vaccine since 1963, measles outbreaks continue worldwide. This article seeks to provide emergency physicians with the contemporary knowledge required to rapidly diagnose potential measles cases and bolster public health measures to reduce ongoing transmission.
  • Thumbnail Image
    Item
    Pharmacokinetics of Antidepressants in Pregnancy
    (Wiley, 2023) Yue, Min; Kus, Lauren; Katta, Shilpa; Su, Isaac; Li, Lang; Haas, David M.; Quinney, Sara K.; Obstetrics and Gynecology, School of Medicine
    Depression is common in pregnant women. However, the rate of antidepressant treatment in pregnancy is significantly lower than in nonpregnant women. Although some antidepressants may cause potential risks to the fetus, not treating or withdrawing the treatment is associated with relapsing and adverse pregnancy outcomes such as preterm birth. Pregnancy-associated physiologic changes can alter pharmacokinetics (PK) and may impact dosing requirements during pregnancy. However, pregnant women are largely excluded from PK studies. Dose extrapolation from the nonpregnant population could lead to ineffective doses or increased risk of adverse events. To better understand PK changes during pregnancy and guide dosing decisions, we conducted a literature review to catalog PK studies of antidepressants in pregnancy, with a focus on maternal PK differences from the nonpregnant population and fetal exposure. We identified 40 studies on 15 drugs, with most data from patients taking selective serotonin reuptake inhibitors and venlafaxine. Most of the studies have relatively poor quality, with small sample sizes, reporting concentrations at delivery only, a large amount of missing data, and not including times and adequate dose information. Only four studies collected multiple samples following a dose and reported PK parameters. In general, there are limited data available regarding PK of antidepressants in pregnancy and deficiencies in data reporting. Future studies should provide accurate information on drug dosing and timing of dose, PK sample collection, and individual-level PK data.